Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology GroupJoann L. Ater, Ian F. Pollack, Tianni Zhou et al.|Journal of Clinical Oncology|2012Cited by 433
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patientsCatherine Patte, Mitchell S. Cairo, Anne Aupérin et al.|Blood|2006Cited by 431
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescentsMitchell S. Cairo, Catherine Patte, Mary Gerrard et al.|Blood|2006Cited by 362
Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium StudyRichard H. Ko, Mignon L. Loh, Lingyun Ji et al.|Journal of Clinical Oncology|2009Cited by 276
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemiaDeepa Bhojwani, Susan R. Rheingold, Sarah Alexander et al.|Leukemia|2018Cited by 209